The Detroit auto show had a lot of us buzzing about the  carmakers last week.  Let’s face it, new models and new innovations are  exciting. But investors might be wise to pay some attention to auto-industry companies that weren’t making headlines at the auto show.
BorgWarner (NYSE: BWA) may have may have slipped under your radar last week, but it shouldn’t have. The Michigan-based parts supplier shot up 14 percent after revving its outlook for 2012. The  company now expects earnings to grow at 23% to 27% over last year, with  sales growth in the area of 10-12% over 2011. Even after last week’s  surge, BWA still sells for 16.7 times earnings. At its projected rate of  growth, it’s now selling at a forward P/E of 13.
And  despite some serious appreciation in value over the past couple years,  BorgWarner has a bright future. The company’s focus is on making  components that maximize fuel efficiency and reduce emissions from  gasoline and diesel engines. High fuel prices, consumer  values and government regulations should only help to heighten the need  for those products in years to come.
BWA counts just about every major manufacturer among its customers, as well as John Deere. Electric  cars like Nissan’s Leaf and GM’s Volt have generated a lot of attention  over the past couple years. But the gasoline engine is not going away  anytime soon, especially with American oil discoveries on a furious  upward clip. BWA’s products are making the good old gas engine kinder to the environment, not to mention easier on the wallet at the pump.
So  while BWA has had an incredible run from the lows of 2009 -- including a  near-double in 2010 -- it still has fuel in the tank. Maybe we can  chalk that up to the company’s fuel-efficient parts. Any pullback in price could make BorgWarner look cheap. It’s my smallest holding, so I’m willing to add more. I’ll be waiting to see if the stock takes a breather here before adding shares.
And one to watch for ...
Johnson Controls (NYSE: JCI),  another maker of auto parts, reports earnings this Thursday. Johnson  Controls has increased sales each quarter for the past seven quarters. 
JCI’s  sales have grown an average of more than 21% percent per year since  2009, and eclipsed its 2008 sales mark of $38 billion last year. It also  bested its 2008 earnings, registering $2.36 per share in 2011. Yet Johnson’s selling at cheaper prices than it was in 2007 and 2008. It currently sells at a P/E of 15.
JCI  makes car seats, consoles, instrument panels and electronics for Ford,  GM, Daimler and other carmakers. It’s the largest car seat supplier in  the world. It also makes batteries for hybrid and electric  vehicles, as well as for advanced “start-stop” gasoline engines. And  it’s building a manufacturing plant to make lithium-ion batteries for  hybrids -- with $300 million in help from Uncle Sam. So, like  Borg-Warner, JCI has a foot in the future of automotive sales as well as  one in the present.
 Johnson is far  from a pure play on car and truck sales. About 36 percent of its sales  in 2011 were from a host of other products, including all types of  controls for buildings, whether it be for lights, security, heating or  air conditioning. But don’t let that scare you away. Many  of Johnson’s building products are designed to improve efficiency,  another trend we can expect to continue. If JCI interests you, tune in for Thursday’s quarterly earnings report.
There's always something to worry about
Slowing  economies in Europe and other parts of the world could hurt suppliers,  including BWA and JCI, since car sales will lag. Inflationary pressures  and rising raw materials costs also pose risks.
But  BWA’s forecast for growth accounts for those factors, so investors  should take that as a sign of confidence from the parts manufacturer. These  two companies look attractive at today’s prices and are positioned to  do well in the years ahead. Investors would be wise to give them a test  drive.
In addition to appearing on this site, this column was syndicated by the Motley Fool.  
 
 
No comments:
Post a Comment